BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25209576)

  • 1. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
    Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
    Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-quantitative dopamine transporter standardized uptake value in comparison with conventional specific binding ratio in [123I] FP-CIT single-photon emission computed tomography (DaTscan).
    Wakabayashi Y; Takahashi R; Kanda T; Zeng F; Nogami M; Ishii K; Murakami T
    Neurol Sci; 2018 Aug; 39(8):1401-1407. PubMed ID: 29748936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
    Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
    Koch W; Radau PE; Hamann C; Tatsch K
    J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of the specific uptake size index for semi-quantitative analysis of I-123-FP-CIT SPECT: harmonized multi-center research setting versus typical clinical single-camera setting.
    Buchert R; Lange C; Spehl TS; Apostolova I; Frings L; Jonsson C; Meyer PT; Hellwig S
    EJNMMI Res; 2019 May; 9(1):37. PubMed ID: 31065816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls.
    Buchert R; Kluge A; Tossici-Bolt L; Dickson J; Bronzel M; Lange C; Asenbaum S; Booij J; Atay Kapucu LÖ; Svarer C; Koulibaly PM; Nobili F; Pagani M; Sabri O; Sera T; Tatsch K; Vander Borght T; Van Laere K; Varrone A; Iida H
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1323-36. PubMed ID: 26816194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the BasGan algorithm for [123I]FP-CIT SPECT quantification: a phantom study.
    Poli GL; Bianchi C; Guerra UP
    Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):391-400. PubMed ID: 23752689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
    Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
    J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
    Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
    J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a resolution-independent method for the quantification of 123I-FP-CIT SPECT scans.
    Goethals I; Dobbeleir A; Ham H; Santens P; D'Asseler Y
    Nucl Med Commun; 2007 Oct; 28(10):771-4. PubMed ID: 17728606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
    Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
    Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.
    Nikolaus S; Wirrwar A; Antke C; Arkian S; Schramm N; Müller HW; Larisch R
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):308-13. PubMed ID: 15791440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined visual and semi-quantitative assessment of
    Ueda J; Yoshimura H; Shimizu K; Hino M; Kohara N
    Neurol Sci; 2017 Jul; 38(7):1187-1191. PubMed ID: 28389938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.
    Buchert R; Hutton C; Lange C; Hoppe P; Makowski M; Bamousa T; Platsch G; Brenner W; Declerck J
    Nucl Med Commun; 2016 May; 37(5):509-18. PubMed ID: 26703759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided diagnosis of Parkinson's disease based on [(123)I]FP-CIT SPECT binding potential images, using the voxels-as-features approach and support vector machines.
    Oliveira FP; Castelo-Branco M
    J Neural Eng; 2015 Apr; 12(2):026008. PubMed ID: 25710187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of brain atrophy in quantitative analysis of
    Hayashi T; Mishina M; Sakamaki M; Sakamoto Y; Suda S; Kimura K
    Ann Nucl Med; 2019 Aug; 33(8):579-585. PubMed ID: 31140153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies?
    Koch W; Hamann C; Welsch J; Pöpperl G; Radau PE; Tatsch K
    J Nucl Med; 2005 Nov; 46(11):1804-11. PubMed ID: 16269593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.